Gas gangrene medical therapy: Difference between revisions
Shanshan Cen (talk | contribs) No edit summary |
Shanshan Cen (talk | contribs) No edit summary |
||
Line 34: | Line 34: | ||
[[Category:Emergency medicine]] | [[Category:Emergency medicine]] | ||
[[Category:Primary care]] | [[Category:Primary care]] | ||
[[Category:Infectious Disease Project]] | |||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} |
Revision as of 15:45, 12 August 2015
Gas gangrene Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Gas gangrene medical therapy On the Web |
American Roentgen Ray Society Images of Gas gangrene medical therapy |
Risk calculators and risk factors for Gas gangrene medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
Any significantly massive infection is a medical emergency. In cases of gangrene, the infection is so severe by the time that a diagnosis is made that countering the bacterial load is impossible even with the strongest available antibiotics, for example gentamycin and vancomycin. Antibiotics alone are not effective because they don't penetrate ischemic muscles enough to be effective. There are two major reasons for this; current antibiotics only prevent replication of bacteria and the production of toxins continues in pre-existing bacteria. Also, the extent of injury caused by the infection may leave the muscle tissues so damaged that the body will never be able to replace the lost structures (including vasculature).
Currently, the use of penicillin G and clindamycin combination remains the most effective and preferred treatment.[1]
Medical Therapy
Gas gangrene
Preferred regimen: Penicillin G 3-4 million units IV q4h AND (Clindamycin 900 mg IV q8h OR Tetracycline 500 mg IV q6h)[78]
Antimicrobial regimen
- Gas gangrene[2]
- 1. Empiric antimicrobial therapy
- Preferred regimen (1): Vancomycin 1 g IV q12h AND (Piperacillin-tazobactam 3.375 g q6h
- Preferred regimen (2): Vancomycin 1 g IV q12h AND Ampicillin-sulbactam 3 g IV q6h
- Preferred regimen (2): Vancomycin 1 g IV q12h AND Carbapenem)
- 2. Culture directed antimicrobial therapy
- 2.1 Clostridium perfringens
- Preferred regimen: Penicillin G 24 MU/day IV q4-6h AND Clindamycin 900 mg IV q8h
- Alternative regimen (1): Erythromycin 1 g IV q6h
- Alternative regimen (2): Ceftriaxone 2 g IV q12h
References
- ↑ Stevens, DL.; Bisno, AL.; Chambers, HF.; Everett, ED.; Dellinger, P.; Goldstein, EJ.; Gorbach, SL.; Hirschmann, JV.; Kaplan, EL. (2005). "Practice guidelines for the diagnosis and management of skin and soft-tissue infections". Clin Infect Dis. 41 (10): 1373–406. doi:10.1086/497143. PMID 16231249. Unknown parameter
|month=
ignored (help) - ↑ Gilbert, David (2015). The Sanford guide to antimicrobial therapy. Sperryville, Va: Antimicrobial Therapy. ISBN 978-1930808843.